Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin SR vs Moxifloxacin for AECB
NCT00254566Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of azithromycin in chronic bronchitis (CB) (2 arms), sponsored by Pfizer. Primary endpoint: Percentage of Clinical Cure (Success) at Test of Cure Visit. Started Feb 2006; status: completed.
02
Drugs
azithromycin
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT00254566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254566.